| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/06/20 | 8-K | Current report filing |
|
8 | |
| 10/15/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
100 |
| 08/07/20 | 8-K | Current report filing |
|
5 | |
| 07/29/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/20 | 8-K | Current report filing |
|
7 | |
| 07/08/20 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
5 | |
| 07/01/20 | 8-K | Current report filing |
|
5 | |
| 06/30/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 06/24/20 | 8-K | Current report filing |
|
3 | |
| 06/12/20 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
123 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.